CAS 56-87-1|L-Lysine
| Common Name | L-Lysine | ||
|---|---|---|---|
| CAS Number | 56-87-1 | Molecular Weight | 146.188 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 311.5±32.0 °C at 760 mmHg |
| Molecular Formula | C6H14N2O2 | Melting Point | 215 °C (dec.)(lit.) |
| MSDS | ChineseUSA | Flash Point | 142.2±25.1 °C |
Names
| Name | L-lysine |
|---|---|
| Synonym | More Synonyms |
L-Lysine BiologicalActivity
| Description | L-lysine is an essential amino acid[1][2] with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions[2]. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Inflammation/Immunology |
| Target | L-lysine (150 mg/kg) promotes, but not initiates, bladder cancer. The administration of L-lysine to rats submitted to colovesical cystoplasty accelerates the development of transitional metaplasia of the intestinal epithelium[1]. L-lysine (10 mg/kg) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity[2]. |
| References | [1]. Santos AMD, et al. Transitional metaplasia in intestinal epithelium of rats submitted to intestinal cystoplasty and treatment with L -lysine. Acta Cir Bras. 2017 Apr;32(4):297-306. [2]. Al-Malki AL. Suppression of acute pancreatitis by L-lysine in mice. BMC Complement Altern Med. 2015 Jun 23;15:193. |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 311.5±32.0 °C at 760 mmHg |
| Melting Point | 215 °C (dec.)(lit.) |
| Molecular Formula | C6H14N2O2 |
| Molecular Weight | 146.188 |
| Flash Point | 142.2±25.1 °C |
| Exact Mass | 146.105530 |
| PSA | 89.34000 |
| LogP | -1.04 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.503 |
| InChIKey | KDXKERNSBIXSRK-YFKPBYRVSA-N |
| SMILES | NCCCCC(N)C(=O)O |
| Storage condition | Store at RT. |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| Water Solubility | H2O: 0.1 g/mL, clear, colorless |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 138 gm/kg
- SEX/DURATION :
- female 5-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - other measures of fertility Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 72450 mg/kg
- SEX/DURATION :
- female 10-20 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 90450 mg/kg
- SEX/DURATION :
- female 10-20 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 81 gm/kg
- SEX/DURATION :
- female 10-20 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 44 gm/kg
- SEX/DURATION :
- female 5-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - other measures of fertility
MUTATION DATA - TYPE OF TEST :
- Sister chromatid exchange
- TEST SYSTEM :
- Human Lymphocyte
- DOSE/DURATION :
- 10 mg/L
- REFERENCE :
- MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 372,75,1996 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-RUSSIA:STEL 5 mg/m3 JAN 1993
- TYPE OF TEST :
- Sister chromatid exchange
- TEST SYSTEM :
- Human Lymphocyte
- DOSE/DURATION :
- 10 mg/L
- REFERENCE :
- MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 372,75,1996 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-RUSSIA:STEL 5 mg/m3 JAN 1993
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | OL5540000 |
| HS Code | 2922411000 |
Customs
| HS Code | 2922411000 |
|---|---|
| Summary | HS: 2922411000. 2,6-diaminohexanoic acid. VAT:17.0%. tax rebate rate:9.0%. supervision conditions:ab(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tarrif:5.0%. general tariff:20.0% |
Articles351
More Articles| Crystal structures and kinetics of Type III 3-phosphoglycerate dehydrogenase reveal catalysis by lysine. FEBS J. 281(24) , 5498-512, (2014) D-Phosphoglycerate dehydrogenase (PGDH) catalyzes the first committed step of the phosphorylated serine biosynthesis pathway. Here, we report for the first time, the crystal structures of Type IIIK PG... | |
| ALD1 Regulates Basal Immune Components and Early Inducible Defense Responses in Arabidopsis. Mol. Plant Microbe Interact. 28(4) , 455-66, (2015) Robust immunity requires basal defense machinery to mediate timely responses and feedback cycles to amplify defenses against potentially spreading infections. AGD2-LIKE DEFENSE RESPONSE PROTEIN 1 (ALD... | |
| Mechanistic studies on the flavin-dependent N⁶-lysine monooxygenase MbsG reveal an unusual control for catalysis. Arch. Biochem. Biophys. 550-551 , 58-66, (2014) The mechanism of Mycobacterium smegmatis G (MbsG), a flavin-dependent l-lysine monooxygenase, was investigated under steady-state and rapid reaction conditions using primary and solvent kinetic isotop... |
Synonyms
| L-lys |
| Lisina [Spanish] |
| 6-Amino-L-norleucine |
| (+)-S-Lysine |
| Lys |
| L-Lysine (9CI) |
| (l)-lysine |
| (S)-(+)-Lysine |
| Aminutrin |
| Lysine acid |
| (S)-a,e-Diaminocaproic Acid |
| Lysinum [Latin] |
| (S)-lysine |
| Lysine |
| 2,6-Diaminohexanoic acid, (S)- |
| FEMA 3847 |
| (S)-2,6-diamino-Hexanoic acid |
| L-Lysine |
| Lysine, L- |
| MFCD00064433 |
| EINECS 200-294-2 |
| H-Lys-OH |
| L-lysine zwitterion |
